UK markets closed
  • FTSE 100

    +40.75 (+0.54%)
  • FTSE 250

    +83.25 (+0.45%)
  • AIM

    +2.59 (+0.36%)

    -0.0005 (-0.04%)

    -0.0043 (-0.34%)
  • Bitcoin GBP

    -205.45 (-0.58%)
  • CMC Crypto 200

    +18.10 (+2.02%)
  • S&P 500

    +18.78 (+0.41%)
  • DOW

    +130.49 (+0.36%)

    +1.92 (+2.77%)

    -25.60 (-1.25%)
  • NIKKEI 225

    -550.45 (-1.68%)

    -11.52 (-0.07%)
  • DAX

    +130.23 (+0.78%)
  • CAC 40

    +98.03 (+1.32%)

Global Stem Cells Market to Reach $532.29 Million by 2027

Company Logo
Company Logo

Global Stem Cells Market

Global Stem Cells Market
Global Stem Cells Market

Dublin, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The "Global Stem Cells Market (2022-2027) by Product, Technology, Source, Applications, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis" report has been added to's offering.

The Global Stem Cells Market is estimated to be worth USD 242.16 million in 2022, and is expected to reach USD 532.29 million by 2027, growing at a CAGR of 17.06%.

Market Segmentation

The Global Stem Cells Market is segmented based on Product, Technology, Source, Applications, and Geography.

  • By Product, the market is classified into Adult Stem Cells (ASCs), Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, and Very Small Embryonic Like Stem Cells.

  • By Technology, the market is classified into Cell Acquisition, Cell Production, Cryopreservation, and Expansion & Sub-Culture.

  • By Source, the market is classified into Autologous and Allogenic.

  • By Applications, the market is classified into Regenerative Medicines and Drug Discovery & Development.

  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)

  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)

  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

The Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Stem Cells Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

  • The Global Stem Cells Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

  • Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.

Why Buy This Report?

  • The report offers a comprehensive evaluation of the Global Stem Cells Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.

  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.

  • The report also includes the regulatory scenario within the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules & regulations imposed on this sector across various geographies.

  • The report also contains competitive analysis using 'Positioning Quadrants'; a proprietary competitive positioning tool.

Market Dynamics


  • Rising Funds For Accelerating Stem Cell Research

  • Growing Demand For Stem Cell Banking

  • Increasing Prevalence Of Genetic Disorders


  • Lack of a Well-Defined Regulatory Framework in Certain Applications of Stem Cell


  • Ongoing Developments in Regenerative Medicine


  • Ethical Concern Related to Stem Cell Research

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Stem Cells Market, by Product

7 Global Stem Cells Market, by Technology

8 Global Stem Cells Market, by Source

9 Global Stem Cells Market, by Applications

10 Americas' Stem Cells Market

11 Europe's Stem Cells Market

12 Middle East and Africa's Stem Cells Market

13 APAC's Stem Cells Market

14 Competitive Landscape

15 Company Profiles

16 Appendix

Companies Mentioned

  • AlloSource, Inc.

  • Anterogen Co. Ltd.

  • Athersys, Inc.

  • BioRestorative Therapies, Inc.

  • Cellular Biomedicine Group, Inc.


  • Gamida-Cell Ltd.

  • Holostem Terapie Avanzate S.r.l

  • Hope Biosciences

  • Kangstem Biotech Co. Ltd.

  • Medipost Co. Ltd.

  • NuVasive, Inc.

  • Orthofix

  • Pharmicell Co. Ltd.

  • Pluristem Therapeutics, Inc.

  • Smith & Nephew PLC

  • Stempeutics Research Pvt. Ltd.

  • Takeda Pharmaceutical Company Ltd.

  • ViaCyte, Inc.

  • JCR Pharmaceuticals Co. Ltd.

For more information about this report visit


CONTACT: CONTACT: Laura Wood,Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900